# US 2020/0002375 A1 · Dual mass spectrometry-cleavable crosslinking reagents for protein-protein interactions

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2020/0002375 A1
- Document ID: US20200002375A1
- Status: Published application
- Kind: A1
- Application number: 16/307,375
- Filed: 2017-06-05
- Published: 2020-01-02
- Earliest claimed: 2016-06-05
- Assignees: Board of Regents, The University of Texas System
- Applicants: Board of Regents, the University of Texas System
- Inventors: Saiful Mahmud Chowdhury
- Web page: https://patentgrep.com/patent/US20200002375A1

## CPC

- C07K 5/1008: {the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala}
- C07K 5/0819: {with the first amino acid being acidic}
- C07K 5/126: {Tetrapeptides}
- C07K 7/06: having 5 to 11 amino acids
- G01N 33/6848: {Methods of protein analysis involving mass spectrometry}
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

Described are dual mass-spectrometry-cleavable cross-linkers that can be cleaved selectively using two differential tandem mass-spectrometric techniques such as collision induced dissociation (CID) or electron transfer dissociation (ETD), i.e., a dual cleavable crosslinking technology (DUCCT) cross-linker. When used to cross-link a macromolecule, such as a peptide, MS/MS fragmentation produces two signature complementary mass spectra of same cross-linked peptides, the analysis of which gives rise to high confidence in characterizing the structures of the cross-linked macromolecules as well as sites of interactions. Also described, are methods of making and using DUCCT cross-linkers.

## Claims

### Claim 1

A cross-linker comprising at least two reactive groups, and at least a first cleavage site and a second cleavage site,
wherein the first cleavage site and the second cleavage site are differentially cleaved by two different mass spectrometric techniques, and
wherein the first cleavage site and second cleavage site are located in a spacer or linker region of the cross-linker between at least two reactive groups.

### Claim 2 (depends on 1)

The cross-linker of claim 1, wherein the through-space distance between at least two reactive groups is between 9 Å and 25 Å, inclusive, 9 Å and 18 Å, inclusive, 9 Å and 13 Å, inclusive, or between 11 Å and 12 Å, inclusive.

### Claim 3 (depends on 1)

The cross-linker of claim 1, wherein the two different mass spectrometric techniques are selected from the group consisting of collision induced dissociation (CID), electron transfer dissociation (ETD), and electron capture dissociation (ECD).

### Claim 4 (depends on 1)

The cross-linker of claim 1, wherein the reactive groups are the same or different.

### Claim 5 (depends on 1)

The cross-linker of claim 1, wherein the reactive groups are selected from the group consisting of each occurrence of a first reactive group and a second reactive group is independently N-hydroxysuccinimide ester, sulfo-N-hydroxysuccinimide ester, maleimide, sulfydryl, hydroxyl, amine, azide, glycidyl, aldehyde, diazirine, diazoacetate ester, acrylate, nitrophenyl ester, nitrile, or a combination thereof.

### Claim 6 (depends on 1)

The cross-linker of claim 1, having the formula:
wherein:
a, b, and c are independently integers between 0 and 20, inclusive, with the proviso that a and b are each at least 1;
d and e are independently integers between 1 and 20, inclusive;
the first cleavage site and the second cleavage site are independently amide bonds, nitrogen-nitrogen hydrazone bond, or a C—Cα bond in peptides;
each occurrence of L1, L2, and L3 is independently an amino acid, —C(O)-unsubstituted heteroaryl-, —C(O)-substituted heteroaryl-, -unsubstituted aryl-(CO)—, -substituted aryl-(CO)—, —C(O)NH—, —C(O)NR′—, —NR′C(O)—, —C(O)O—, —OC(O)—, —C(O)OCH2—, —SO2NR′—, —CH2R′—, —O—, —NR′H—, —NR′—, —OCONH—, —NHCOO—, —OCONR′—, —NR′COO—, —NHCONH—, —NR′CONH—, —NHCONR′—, —NR′CONR′—, —CHOH—, —CR′OH—, unsubstituted alkyl (such as unsubstituted C1-C20 alkyl, unsubstituted C1-C10 alkyl, unsubstituted C1-C5 alkyl), substituted alkyl (such as substituted C1-C20 alkyl, substituted C1-C10 alkyl, substituted C1-C5 alkyl), unsubstituted alkylene (such as unsubstituted C1-C20 alkylene, unsubstituted C1-C10 alkylene, unsubstituted C1-C5 alkylene), substituted alkylene (such as substituted C1-C20 alkylene, substituted C1-C10 alkylene, substituted C1-C5 alkylene), substituted alkenyl (such as substituted C1-C20 alkenyl, substituted C1-C10 alkenyl, substituted C1-C5 alkenyl), unsubstituted alkenyl (such as unsubstituted C1-C20 alkenyl, unsubstituted C1-C10 alkenyl, unsubstituted C1-C5 alkenyl), substituted alkylamino (such as substituted C1-C20 alkylamino, substituted C1-C10 alkylamino, substituted C1-C5 alkylamino), unsubstituted alkylamino (such as unsubstituted C1-C20 alkylamino, unsubstituted C1-C10 alkylamino, unsubstituted C1-C5 alkylamino), substituted carbonyl (such as substituted C1-C20 carbonyl, substituted C1-C10 carbonyl, substituted C1-C5 carbonyl), or unsubstituted carbonyl (such as unsubstituted C1-C20 carbonyl, unsubstituted C1-C10 carbonyl, unsubstituted C1-C5 carbonyl); an affinity group, or a combination thereof; and R′ is hydrogen, halogen (F, Cl, Br, I), hydroxyl, unsubstituted alkyl (such as unsubstituted C1-C20 alkyl), substituted alkyl (such as substituted C1-C20 alkyl), substituted alkylene (such as substituted C1-C20 alkylene), unsubstituted alkylene (such as unsubstituted C1-C20 alkylene), substituted alkenyl (such as substituted C1-C20 alkenyl), unsubstituted alkenyl (such as unsubstituted C1-C20 alkenyl), substituted alkylamino (such as substituted C1-C20 alkylamino), unsubstituted alkylamino (such as unsubstituted C1-C20 alkylamino), substituted carbonyl (such as substituted C1-C20 carbonyl), or unsubstituted carbonyl (such as unsubstituted C1-C20 carbonyl), an aryl group, or a heterocyclic group; and
Ax is independently one or more amino acids, —C(O)—(CH2)n—O-substituted aryl-substituted alkyl-, —C(O)—(CH2)n—O-unsubstituted aryl-substituted alkyl-, —C(O)—(CH2)n—O-substituted heteroaryl-substituted alkyl-, —C(O)—(CH2)n—O-unsubstituted heteroaryl-substituted alkyl-, —C(O)—(CH2)n—, —C(O)NH—, —C(O)NR′—, —NR′C(O)—, —C(O)O—, —OC(O)—, —C(O)OCH2—, —SO2NR′—, —CH2R′—, —O—, —NR′H—, —NR′—, —OCONH—, —NHCOO—, —OCONR′—, —NR′COO—, —NHCONH—, —NR′CONH—, —NHCONR′—, —NR′CONR′—, —CHOH—, —CR′OH—, unsubstituted alkyl (such as unsubstituted C1-C20 alkyl, unsubstituted C1-C10 alkyl, unsubstituted C1-C5 alkyl), substituted alkyl (such as substituted C1-C20 alkyl, substituted C1-C10 alkyl, substituted C1-C5 alkyl), unsubstituted alkylene (such as unsubstituted C1-C20 alkylene, unsubstituted C1-C10 alkylene, unsubstituted C1-C5 alkylene), substituted alkylene (such as substituted C1-C20 alkylene, substituted C1-C10 alkylene, substituted C1-C5 alkylene), substituted alkenyl (such as substituted C1-C20 alkenyl, substituted C1-C10 alkenyl, substituted C1-C5 alkenyl), unsubstituted alkenyl (such as unsubstituted C1-C20 alkenyl, unsubstituted C1-C10 alkenyl, unsubstituted C1-C5 alkenyl), substituted alkylamino (such as substituted C1-C20 alkylamino, substituted C1-C10 alkylamino, substituted C1-C5 alkylamino), unsubstituted alkylamino (such as unsubstituted C1-C20 alkylamino, unsubstituted C1-C10 alkylamino, unsubstituted C1-C5 alkylamino), substituted carbonyl (such as substituted C1-C20 carbonyl, substituted C1-C10 carbonyl, substituted C1-C5 carbonyl), or unsubstituted carbonyl (such as unsubstituted C1-C20 carbonyl, unsubstituted C1-C10 carbonyl, unsubstituted C1-C5 carbonyl), an affinity group, or a combination thereof, wherein n is an integer between 1 and 10, inclusive; R′ is hydrogen, halogen (F, Cl, Br, I), hydroxyl, unsubstituted alkyl (such as unsubstituted C1-C20 alkyl), substituted alkyl (such as substituted C1-C20 alkyl), substituted alkylene (such as substituted C1-C20 alkylene), unsubstituted alkylene (such as unsubstituted C1-C20 alkylene), substituted alkenyl (such as substituted C1-C20 alkenyl), unsubstituted alkenyl (such as unsubstituted C1-C20 alkenyl), substituted alkylamino (such as substituted C1-C20 alkylamino), unsubstituted alkylamino (such as unsubstituted C1-C20 alkylamino), substituted carbonyl (such as substituted C1-C20 carbonyl), or unsubstituted carbonyl (such as unsubstituted C1-C20 carbonyl).

### Claim 7 (depends on 1)

The cross-linker of claim 1, wherein the first cleavage site comprises
Pro-X Formula II
wherein, Pro is proline, and X is aspartate.

### Claim 8 (depends on 1)

The cross-linker of claim 1, wherein the second cleavage site comprises a nitrogen-nitrogen hydrazone bond.

### Claim 9 (depends on 6)

The cross-linker of claim 6, having the formula:

### Claim 10 (depends on 6)

The cross-linker of claim 6, wherein L1 is aspartate.

### Claim 11 (depends on 6)

The cross-linker of claim 6, wherein the first cleavage site is Pro-Asp.

### Claim 12 (depends on 6)

The cross-linker of claim 6, wherein L2 is —C(O)-unsubstituted heteroaryl-, or —C(O)-substituted heteroaryl.

### Claim 13 (depends on 6)

The cross-linker of claim 6, wherein the second cleavage site is a nitrogen-nitrogen hydrazone bond.

### Claim 14 (depends on 6)

The cross-linker of claim 6, wherein L3 is -unsubstituted aryl-C(O)—, or -substituted aryl-C(O)—.

### Claim 15 (depends on 6)

The cross-linker of claim 6, wherein the first reactive group and second reactive group are N-hydroxysuccimide ester.

### Claim 16 (depends on 6)

The cross-linker of claim 6, wherein Ax is glycine.

### Claim 17 (depends on 6)

The cross-linker of claim 6, wherein Ax is selected from the group consisting of one or more amino acids, —C(O)—(CH2)n—O-substituted aryl-substituted alkyl-, —C(O)—(CH2)n—O-unsubstituted aryl-substituted alkyl-, —C(O)—(CH2)n—O-substituted heteroaryl-substituted alkyl-, —C(O)—(CH2)n—O-unsubstituted heteroaryl-substituted alkyl-, —C(O)—(CH2)n—, an affinity group, or a combination thereof

### Claim 18 (depends on 17)

The cross-linker of claim 17, wherein n is 3, 4, or a combination thereof

### Claim 19 (depends on 18)

The cross-linker of claim 18, wherein the one or more amino acids are selected from the group consisting of glycine, glutamate, and lysine.

### Claim 20 (depends on 6)

The cross-linker of claim 6, wherein Ax is selected from the group consisting of one or more amino acids, —C(O)—(CH2)n—, an affinity group.

### Claim 21 (depends on 20)

The cross-linker of claim 20, wherein n is 4.

### Claim 22 (depends on 21)

The cross-linker of claim 21, wherein the one or more amino acids are selected from the group consisting of glycine and lysine.

### Claim 23 (depends on 6)

The cross-linker of claim 6, wherein the affinity group is selected from the group consisting of biotin, hemagglutinin, streptavidin, fusion protein, purification tags, antibodies or antigen-binding fragment thereof, an RNA or protein shaped to specifically interact with a target (e.g., an RNA- or peptide-aptamer), a small molecule or element with specific binding affinity (e.g., biotin which binds streptavidin, or iron which is bound by the transferrin receptor) or a ligand for a cell a cell-surface receptor or cell-surface antigen.

### Claim 24 (depends on 1)

The cross-linker of claim 1, for proteins and protein complexes, wherein the cross-linker has a CID cleavable site and an ETD cleavable site.

### Claim 25 (depends on 1)

The cross-linker of claim 1, having the formula:

### Claim 26 (depends on 1)

The cross-linker of claim 1, wherein at least one of the reactive groups binds to a macromolecule or a complex comprising a macromolecule, wherein the macromolecule or complex comprising the macromolecule is selected from the group consisting of receptor/ligand complex; biotin avidin complex, peptide/S ribonuclease complex, digoxigenin/anti-digoxigenin antibody complex, complimentary oligonucleotide pair complex and antibody/ligand complex.

### Claim 27 (depends on 1)

The cross-linker of claim 1 comprising a detectable moiety linked to a photoreactive moiety, wherein the photoreactive moiety comprises at least one group covalently bound to a substrate to form a conjugate that can be selectively photocleaved to release said substrate, wherein said substrate is selected from proteins, peptides, amino acids, lipids, cells, virus particles, fatty acids, polysaccharides and inorganic molecules.

### Claim 28 (depends on 1)

A method for mapping protein-protein interactions of a protein complex, the method comprising:
contacting the cross-linker of claim 1 under conditions in which two or more reactive groups in the multivalent cross-linker react with a reactive group in the protein complex to form a cross-linked protein complex;
digesting the protein complex with an enzyme such as trypsin to form peptides and/or peptide fragments; and
using mass spectrometry (MSz) to identify the protein and/or peptide fragments, wherein Z is an integer between 1 and 4, inclusive, such as 1, 2, 3, or 4.
